The place of combined oral contraceptives in contraception

Cephalalgia

Volumn 20, Issue 3, 2000, Pages 157-163

  MacGregor, E A ^a,c   De Lignieres B ^a,b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b Hôpital Necher   (France)

^c City of London Migraine Clinic   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; COPPER INTRAUTERINE DEVICE; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ACNE; ARTICLE; BLEEDING; CANCER; CEREBROVASCULAR ACCIDENT; CONTRACEPTION; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; FEMALE; FEMALE STERILIZATION; HIGH RISK POPULATION; HUMAN; IMPLANT; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; MALE STERILIZATION; RISK ASSESSMENT; THROMBOEMBOLISM;

BREAST NEOPLASMS; CEREBROVASCULAR ACCIDENT; CONTRACEPTION; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HUMANS; ISCHEMIA; MIGRAINE DISORDERS; ODDS RATIO; OVULATION; PROGESTERONE CONGENERS; RISK FACTORS;

EID: 0034453873     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2000.00036.x     Document Type: Article

References (29)

1. Oral contraception and blood coagulability
2. Thrombo-embolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs
3. Contraceptive hormones and their clinical use
4. Patterns of contraceptive pill-taking in an inner city practice
5. Comparative pharmacology of newer progestogens
6. Oral contraception and cancer
7. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies
8. Mortality associated with oral contraceptive use: 25 Year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study
9. Neoplasia of the cervix uteri and contraception: A possible adverse effect of the pill
10. Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case-control study
11. Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation
12. Acute myocardial infarction and the combined pill: Results of an international multicentre case control study
13. Oral contraceptives and myocardial infarction: Results of the MICA case-control study
14. Third generation oral contraceptives and risk of myocardial infarction: An international case-control study
15. Oral contraceptives and stroke in young women: Associated risk factors
16. Case-control of migraine and risk of ischaemic stroke in young women
17. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: The influence of diabetes, hypertension, migraine, and previous thrombotic disease
18. History of migraine and risk of cerebral ischaemia in young adults
19. Ischaemic stroke and combined oral contraceptives; results of an international, multicentre, case-control study
20. Case-control study of oral contraceptives and risk of thromboembolic stroke: Results from international study on oral contraceptives and health of young women
21. Migraine and stroke in young women: Case-control study
22. Effect on stroke of different progestogens in low oestrogen dose oral contraceptives
23. Migraine and oral contraceptives
24. Pregnancy and the risk of stroke
25. Risk of cardiovascular diseases associated with oral progestogen preparations with therapeutic indications
26. Combined hormone replacement therapy does not protect women against age-related decline in endothelium-dependent vasomotor function